Alamar Biosciences: Insider Ownership Change Reported
Ticker: ALMR · Form: 4 · Filed: Apr 21, 2026 · CIK: 0002104204
Sentiment: neutral
Topics: insider-filing, ownership-change
TL;DR
Alamar Biosciences insider Nicholas Naclerio filed a Form 4 on 4/20/26 detailing ownership changes as of 4/16/26.
AI Summary
On April 16, 2026, Nicholas Naclerio, a reporting person associated with Alamar Biosciences, Inc., reported a change in beneficial ownership of securities. The filing details transactions related to Alamar Biosciences, Inc., a company incorporated in Delaware with a fiscal year end of December 31st.
Why It Matters
Form 4 filings indicate changes in the stock ownership of company insiders, which can signal their confidence or concerns about the company's future performance.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of changes in beneficial ownership and does not inherently indicate increased risk.
Key Numbers
- 2026-04-16 — Period of Report (Date of transaction/change)
- 2026-04-20 — Filing Date (Date the report was accepted by SEC)
Key Players & Entities
- Nicholas Naclerio (person) — Reporting Person
- Alamar Biosciences, Inc. (company) — Issuer
- ILLUMINA, INC. (company) — Mailing Address Recipient
FAQ
Who is the reporting person and what is their relation to Alamar Biosciences, Inc.?
Nicholas Naclerio is the reporting person, and the filing indicates he is associated with Alamar Biosciences, Inc. as a reporting person.
What type of form was filed?
A Form 4 - Statement of changes in beneficial ownership of securities was filed.
When was the period of report for the transactions?
The period of report was April 16, 2026.
What is the business address of Alamar Biosciences, Inc.?
The business address of Alamar Biosciences, Inc. is 47071 BAYSIDE PARKWAY FREMONT CA 94538.
What is the SIC code for Alamar Biosciences, Inc.?
The SIC code for Alamar Biosciences, Inc. is 3826, which corresponds to Laboratory Analytical Instruments.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 21, 2026 by Nicholas Naclerio regarding Alamar Biosciences, Inc. (ALMR). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.